Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Postoperative Hemorrhage D019106 7 associated lipids
Leukostasis D018921 1 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Pelvic Pain D017699 7 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lee T et al. Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase. 2001 Arch. Biochem. Biophys. pmid:11368182
Iwase M et al. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. 2001 Crit. Care Med. pmid:11373429
Jehle R et al. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. 2001 Biochim. Biophys. Acta pmid:11420174
Kulikov VI and Muzya GI Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs. 2001 Biochemistry Mosc. pmid:11421815
Virchow JC et al. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. 2001 Clin. Exp. Allergy pmid:11422147
Bachert C Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. 2001 Allergy pmid:11243500
Roudebush WE et al. Impact of blood serum insulin-like growth factor I on platelet-activating factor in bull spermatozoa. 2001 Domest. Anim. Endocrinol. pmid:11164329
Giménez R and Aguilar J Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. 2001 Neurosci. Lett. pmid:11165772
Goudevenos J et al. Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty. 2001 Eur. J. Clin. Invest. pmid:11168434
Galimi F et al. Hepatocyte growth factor is a regulator of monocyte-macrophage function. 2001 J. Immunol. pmid:11145707
Mariano F et al. Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. 2001 Kidney Int. pmid:11576379
Fazal N et al. PAF receptor antagonist modulates neutrophil responses with thermal injury in vivo. 2001 Am. J. Physiol., Cell Physiol. pmid:11546669
Beales IL Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells. 2001 Dig. Dis. Sci. pmid:11284466
McHowat J et al. Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2). 2001 Biochemistry pmid:11732912
Sirolli V et al. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. 2001 Thromb. Haemost. pmid:11583316
Fukunaga K et al. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. 2001 J. Biol. Chem. pmid:11560941
Johnson CD et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. 2001 Gut pmid:11115824
Thom SR et al. Roles for platelet-activating factor and *NO-derived oxidants causing neutrophil adherence after CO poisoning. 2001 Am. J. Physiol. Heart Circ. Physiol. pmid:11454599
Grosman N Similar effects of ether phospholipids, PAF and lyso-PAF on the Ca(2+)-ATPase activity of rat brain synaptosomes and leukocyte membranes. 2001 Int. Immunopharmacol. pmid:11460312
Marathe GK et al. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. 2001 J. Lipid Res. pmid:11518762
Smith DG et al. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. 2001 J. Neurovirol. pmid:11519483
Hoenstein R et al. Interleukin-2 activates human peripheral blood eosinophils. 2001 Cell. Immunol. pmid:11520078
Carceller E et al. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. 2001 J. Med. Chem. pmid:11520209
Uhlmann D et al. Importance of microcirculatory disturbances in the pathogenesis of pancreatitis. 2001 Zentralbl Chir pmid:11753796
Biffl WL et al. Neutrophil apoptosis is delayed by trauma patients' plasma via a mechanism involving proinflammatory phospholipids and protein kinase C. 2001 Surg Infect (Larchmt) pmid:12593704
Richardson RM et al. RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses. 2001 Biochemistry pmid:11297424
Kuijpers TW et al. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. 2001 Clin. Exp. Immunol. pmid:11298128
Teeling JL et al. Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model. 2001 Br. J. Haematol. pmid:11298603
Teather LA et al. Differential interaction of platelet-activating factor and NMDA receptor function in hippocampal and dorsal striatal memory processes. 2001 Neurobiol Learn Mem pmid:11300737
Aiboshi J et al. Blood transfusion and the two-insult model of post-injury multiple organ failure. 2001 Shock pmid:11303730
Ilveskero S et al. Procoagulant activity on platelets adhered to collagen or plasma clot. 2001 Arterioscler. Thromb. Vasc. Biol. pmid:11304482
Chłopicki S et al. Residual pulmonary neutrophils are involved in vaso- and bronchoconstrictor responses to platelet activating factor in the isolated buffer-perfused rat lung. 2000 May-Jun Pol J Pharmacol pmid:11055579
Iglesias-De La Cruz MC et al. Phenotypic modifications of human mesangial cells by extracellular matrix: the importance of matrix in the contractile response to reactive oxygen species. 2000 Mar-Apr Exp. Nephrol. pmid:10729749
Bastos da Silva M et al. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation. 2000 Mar-Apr Vet. Res. pmid:10779205
Sibelius U et al. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. 2000 Jan 4-11 Circulation pmid:10618308
Zouki C et al. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. 2000 FASEB J. pmid:10698973
Hidi R et al. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis. 2000 Eur. Respir. J. pmid:10706503
Chen LW et al. Differential regulation of Ca2+ influx by fMLP and PAF in human neutrophils: possible involvement of store-operated Ca2+ channel. 2000 Shock pmid:10718373
Wang WJ et al. [Effects of musk glucoprotein on PAF production and cytosolic Ca2+ level in rat polymorphonuclear leukocytes in vitro]. 2000 Zhongguo Zhong Yao Za Zhi pmid:12525061
Manabe H et al. The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs. 2000 Pulm Pharmacol Ther pmid:10718985
Sun Z et al. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats. 2000 Dig Surg pmid:10720833
Vallee RB et al. The role of cytoplasmic dynein in the human brain developmental disease lissencephaly. 2000 Biochim. Biophys. Acta pmid:10722879
Asai Y and Watanabe S Characterization of the physicochemical properties of the micelles by the novel platelet activating factor receptor antagonist E5880. 2000 Eur J Pharm Biopharm pmid:10799812
Weintraub ST et al. Mass spectrometric analysis of platelet-activating factor after isolation by solid-phase extraction and direct derivatization with pentafluorobenzoic anhydride. 2000 J. Am. Soc. Mass Spectrom. pmid:10689672
Nilsson G et al. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. 2000 Immunology pmid:10692052
De Plaen IG et al. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. 2000 Br. J. Pharmacol. pmid:10694237
Wang WZ et al. Platelet-activating factor contributes to postischemic vasospasm. 2000 J. Surg. Res. pmid:10729242
Ishii S and Shimizu T Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. 2000 Prog. Lipid Res. pmid:10729607
Berthou C et al. Interferon-gamma-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis. 2000 Blood pmid:10733503
Kaul DK et al. Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. 2000 Blood pmid:10627437
Zaitseva L et al. Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock. 2000 Bull. Exp. Biol. Med. pmid:11177271
Miike S et al. Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils. 2000 J. Leukoc. Biol. pmid:10648006
Kecskeméti V and Balogh I The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study. 2000 J. Physiol. Pharmacol. pmid:11192945
Dichmann S et al. Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation: Ca(++) mobilization and actin reorganization in human eosinophils. 2000 Blood pmid:10648411
Burns AR et al. Analysis of tight junctions during neutrophil transendothelial migration. 2000 J. Cell. Sci. pmid:10591624
McManus LM and Pinckard RN PAF, a putative mediator of oral inflammation. 2000 Crit. Rev. Oral Biol. Med. pmid:12002818
Liao CH et al. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. 2000 J. Pharm. Pharmacol. pmid:10757426
Bailey SR et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. 2000 Res. Vet. Sci. pmid:10756136
Emerson M et al. Characterization and functional significance of calcium transients in the 2-cell mouse embryo induced by an autocrine growth factor. 2000 J. Biol. Chem. pmid:10764773
Munakata M et al. Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure. 2000 Jpn. J. Thorac. Cardiovasc. Surg. pmid:10769990
Connolly AB and Vernon DR Manipulations of the metabolic response for management of patients with severe surgical illness: review. 2000 World J Surg pmid:10773122
Shindou H et al. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. 2000 Biochem. Biophys. Res. Commun. pmid:10814544
Mizutani Y et al. Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. 2000 Biochim. Biophys. Acta pmid:10832103
Oshiro T et al. Characterization of platelet-activating factor-induced cytosolic calcium mobilization in human eosinophils. 2000 Clin. Exp. Allergy pmid:10792362
Ibe BO et al. Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10749711
Hauser CJ et al. Major trauma enhances store-operated calcium influx in human neutrophils. 2000 J Trauma pmid:10780589
Vincent JL et al. Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. 2000 Crit. Care Med. pmid:10752807
Kalia N et al. Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo. 2000 Dig. Dis. Sci. pmid:10759248
Koyama S et al. The potential of various lipopolysaccharides to release IL-8 and G-CSF. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10749742
Hickey MJ et al. L-selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo. 2000 J. Immunol. pmid:11120848
Kaplan R et al. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease. 2000 Br. J. Haematol. pmid:11122160
Bussolati B et al. IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE). 2000 Clin. Exp. Immunol. pmid:11122257
Kelly RF Current strategies in lung preservation. 2000 J. Lab. Clin. Med. pmid:11128744
Alloatti G et al. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. 2000 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11080081
Tjoelker LW and Stafforini DM Platelet-activating factor acetylhydrolases in health and disease. 2000 Biochim. Biophys. Acta pmid:11080681
Tanaka Y et al. Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats. 2000 Br. J. Pharmacol. pmid:11082118
Chroni A and Mavri-Vavayanni M Characterization of a platelet activating factor acetylhydrolase from rat adipocyte. 2000 Life Sci. pmid:11105997
Wechsung E and Houvenaghel A Involvement of platelet activating factor in the endotoxin-induced effects on gastrointestinal electrical activity and some haematological parameters in the conscious miniature pig. 2000 J. Vet. Pharmacol. Ther. pmid:11107007
Dubois MJ and Vincent JL Clinically-oriented therapies in sepsis: a review. 2000 J. Endotoxin Res. pmid:11521072
Tokumura A et al. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase. 2000 J. Lipid Res. pmid:10828088
Davenpeck KL et al. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. 2000 J. Immunol. pmid:10946308
Martin M et al. [Antiretroviral ant anti-inflammatory properties of a novel platelet activation factor antagonist, PMS-601]. 2000 Pathol. Biol. pmid:10949851
Countryman NB et al. Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production. 2000 J. Invest. Dermatol. pmid:10951245
Soeki T et al. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. 2000 Jpn. Circ. J. pmid:10952148
Henig NR et al. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. 2000 Am. J. Respir. Crit. Care Med. pmid:10934081
Haribabu B et al. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. 2000 J. Exp. Med. pmid:10934231
Miyatake T et al. Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. 2000 Transplant. Proc. pmid:10936319
Raible DG et al. Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation. 2000 Free Radic. Biol. Med. pmid:10938462
Baskova I et al. Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech. 2000 Platelets pmid:10938885
Emingil G et al. Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine A. 2000 J. Periodontol. pmid:10695938
Kusuhara H et al. Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells. 2000 Cytokine pmid:10880261
Tektonidou MG et al. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations. 2000 Eur. J. Clin. Invest. pmid:10886305
Aihara M et al. Interaction between neurone and microglia mediated by platelet-activating factor. 2000 Genes Cells pmid:10886367
Kulikov VI and Muzya GI Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. 2000 Biochemistry Mosc. pmid:10810178
Folch E et al. H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis. 2000 Free Radic. Biol. Med. pmid:10889459
Huo LJ and Yang ZM Effects of platelet activating factor on capacitation and acrosome reaction in mouse spermatozoa. 2000 Mol. Reprod. Dev. pmid:10862011
Cavallo-Perin P et al. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria. 2000 Nephrol. Dial. Transplant. pmid:10862637
Bae K et al. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. 2000 J. Biol. Chem. pmid:10867005
Alappatt C et al. Acute keratinocyte damage stimulates platelet-activating factor production. 2000 Arch. Dermatol. Res. pmid:10867814
Yildirim G et al. Does the platelet-activating factor affect the antioxidant defense system? The possible role of hyperbaric oxygenation. 2000 Biol Trace Elem Res pmid:11318001